However, this information is essential because the immune and skeletal systems are closely linked; for example, the receptor activator of nuclear factor-κB ligand (RANKL) stimulation suppresses T-cell killing and enhances immunosuppression in the bone tumor microenvironment [30,31]. Here, TNFSF11 is linked to bone neoplasm.